Related Experiment Videos
Regression of CD8+ pseudolymphoma after HIV antiviral triple therapy
Noël Emile Célestin Schartz1, Arnaud De La Blanchardiére, Siham Alaoui
1Department of Dermatology, Hôpital Saint-Louis AP-HP, Paris, France.
Journal of the American Academy of Dermatology
|July 2, 2003
Abstract:
To our knowledge, we report the first case of improvement of HIV-associated cutaneous CD8(+) pseudolymphoma with highly active antiretroviral therapy. This favors the hypothesis of a reactive cutaneous infiltration by HIV-specific cytotoxic T cells in this disease.